CME Group Stock Faces Scrutiny Amid Record Volumes
CME Group's stock has surged 82.6% over the past five years, but whether it justifies its current price is a different story.
The Excess Returns intrinsic value estimate puts the company's worth at $258.83 per share, which is slightly below the market price of around $284 per share, implying an overvaluation of 8.7%.
The stock trades on a P/E ratio of 23.7x, lower than its peer average and the wider Capital Markets industry average, but still higher than its tailored fair P/E ratio of 15.7x.
Recent record volumes in Henry Hub natural gas futures and strong activity across U.S. Treasury and metals contracts may justify a premium, but competition from newer venues and event or weather-focused trading platforms could limit how much investors are willing to pay for that growth.